НАРУШЕНИЯ ФУНКЦИИ ПОЧЕК У БОЛЬНЫХ ПРИ МЕТАБОЛИЧЕСКОМ СИНДРОМЕ В СОЧЕТАНИИ С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ

1. Мухин Н.А. Снижение скорости клубочковой фильтрации – общепопуляционный маркер неблагоприятного прогноза. Терапевтический архив, 2007 № 6, с. 5-10.

2. Abuaisha B, Kumar S, Malik R, Boulton AJ. Relationship of elevated urinary albumin excretion to components of the metabolic syndrome in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 1998 Feb;39(2):93-9.

3. Andronico G, Ferraro-Mortellaro R, Mangano MT, Rom M, Raspanti F, Pinto A, Licata G, Seddio G, Mul G, Cerasola G. Insulin resistance and glomerular hemodynamics in essential hypertension. Kidney Int. 2002 Sep;62(3):1005-9.

4. Barratt J, Topham P. Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ 2007; 177: 361-68.

5. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S et al. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia 1998; 41: 694–700.

6. Chagnac A, Weinstein T, Korzets A et al. Glomerular hemodynamics in severe obesity. Am J Physiol 2000; 278: F817–22.

7. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004;140:167- 74.

8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289: 2560–2572.

9. De La Sierra A, Bragulat E, Sierra C, Gomez-Angelats E, Antonio MT, Aguilera MT, Coca A.Microalbuminuria in essential hypertension: clinical and biochemical profile. Br J Biomed Sci. 2000;57(4):287-91.

10. Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension. 1996 Jul;28(1):127-32.

11. ESH-ESC Guidelines Committee. European Society of Hypertension-European Society of Cardiology Guidelines Committee: 2007 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2007;25: 1105–1187.

12. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int. 1998 May;53(5):1343-7.

13. Grandi AM, Santillo R, Zanzi P, Broggi R, Imperiale D, Colombo S, Bertolini A, Jessula A, Selva E, Guasti L, Venco A. Microalbuminuria in never-treated hypertensives: lack of relationship to hyperinsulinemia and genetic predisposition to hypertension. Am J Hypertens. 2000 Apr;13(4 Pt 1):353-8.

14. Grundy SM, Brewer HB, Cleeman JI et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/ American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–8.

15. Harrap SB, Cumming AD, Davies DL, Foy CJ, Fraser R, Kamitani A, Connor JM, Lever AF, Watt GC. Glomerular hyperfiltration, high renin, and low- extracellular volume in high blood pressure. Hypertension. 2000 Apr;35(4):952-7.

16. Hebert LA, Spetie DN, Keane WF. The urgent call of albuminuria/ proteinuria. Heeding its significance in early detection of kidney disease. Postgrad Med 2001; 110: 79-82, 87-8, 93-6.

17. Hoffmann IS, Jimenez E, Cubeddu LX. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure. J Hum Hypertens. 2001 Jun;15(6):407-12.

18. Kim YI, Kim CH, Choi CS, Chung YE, Lee MS, Lee SI, Park JY, Hong SK, Lee KU. Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes Res Clin Pract. 2001 May;52(2):145-52.

19. Kincaid-Smith P. Hypothesis: obesity and the insulin resistance syndrome play a major role in end stage renal failure attributed to hypertension and labeled „hypertensive nephrosclerosis“. J Hypertens 2004; 22: 1051-5.

20. Klausen K, Borch-Johnsen K, Feldt Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 32-5.

21. Kubo M, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Hirakata H, Fujishima M. Effect of hyperinsulinemia on renal function in a general Japanese population: the Hisayama study. Kidney Int. 1999 Jun;55(6):2450-6.

22. Lorenzo C, Nath SD, Hanley AJ, Abboud HE, Haffner SM.Relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria. Clin J Am Soc Nephrol. 2008 May;3(3):783-9. Epub 2008 Mar 5.

23. Mul G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G, Mongiov R, Mezzatesta G, Andronico G, Cerasola G. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med. 2005 Jun;257(6):503-13.

24. Mykkanen L, Zaccaro DJ, Wagenknecht LE et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the Insulin Resistance Atherosclerosis Study. Diabetes 1998; 47: 793– 800.

25. Nakamura K., Okamura T., Hayakawa T., et al. Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA 90. Circ. J. 2006:70(8):954-959.

26. Okpechi IG, Pascoe MD, Swanepoel CR, Rayner BL. Microalbuminuria and the metabolic syndrome in non-diabetic black Africans. Diab Vasc Dis Res. 2007 Dec;4(4):365-7.

27. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 2003; 16: 952–8.

28. Pedrinelli R, Dell’Omo G, Penno G, Di Bello V, Giorgi D, Pellegrini G, Del Prato S, Mariani M.Microalbuminuria, a parameter independent of metabolic influences in hypertensive men. J Hypertens 2003 Jun;21(6):1163-9.

29. Pontremoli R, Leoncini G, Viazzi F, Ratto E, Vaccaro V, Falqui V, Parodi A, Conti N, Tomolillo C, Deferrari G. Evaluation of Subclinical Organ Damage for Risk Assessment and Treatment in the Hypertensive Patient: Role of Microalbuminuria. J Am Soc Nephrol 2006;17: S112–S114.

30. Rayner B. Importance of modulating the renin-angiotensin system in preventing renal complications of hypertension. Saudi J Kidney Dis Transpl 2006; 17: 469-80.

31. Redon J, Miralles A, Pascual JM, Bald E, Robles RG, Carmena R. Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension. J Hypertens. 1997 Jan;15(1):79-86.

32. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10 year obser vational follow up study. BMJ 1996; 313: 779-84.

33. Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol 2001; 38: 1782-87.

34. Scaglione R, Argano C, di Chiara T, Colomba D, Parrinello G, Corrao S, Avellone G, Licata G.Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary albumin excretion. Blood Press. 2003;12(5-6):269-76.

35. Schmieder RE, Veelken R, Schobel H, Dominiak P, Mann JF, Luft FC. Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension. J Am Soc Nephrol. 1997 Jun;8(6):893-900.

36. Schrader J, Luders S, Kulschewski A, et al. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*. J Hypertens 2006; 24: 541-8.

37. Srinivasan SR, Myers L, Berenson GS. Risk variables of insulin resistance syndrome in African American and Caucasian young adults with microalbuminuria: the Bogalusa Heart Study. Am J Hypertens 2000; 13: 1274–9.

38. Sukhija R, Aronow WS, Kakar P, et al. Relation of microalbuminuria and coro nary artery disease in patients with and without diabetes mellitus. Am J Cardiol 2006; 98: 279-81.

39. ter Maaten JC, Bakker SJ, Sern EH, ter Wee PM, Donker AJ, Gans RO. Insulin’s acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin’s acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects. Nephrol Dial Transplant. 1999 Oct;14(10):2357-63.

40. Valensi P, Assayag M, Busby M, Pari s J, Lormeau B, Attali JR. Microalbuminuria in obese patients with or without hypertension. Int J Obes Relat Metab Disord. 1996 Jun;20(6):574-9.

41. Whelton PK, He J, Perneger TV, Klag MJ. Kidney damage in ‘benign’ essential hypertension. Curr Opin Nephrol Hypertens. 1997 Mar;6(2):177-83.